SCHEMBL24752199

SCHEMBL24752199

c1ccc(-c2nc(-c3ccc(-c4cccnc4)cc3)cc(-c3ccc(-c4ccc(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)cc4)c4ccccc34)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.42
▸ CYP19A1 P11511 2/20 0.39
▸ CYP11B1 P15538 2/20 0.36
▸ CYP17A1 P05093 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ EGLN1 Q9GZT9 2/20 0.36
▸ METAP2 P50579 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ TSHR P16473 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ GLA P06280 2/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26432151 0.97 DHODH (0.43) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL24752202 0.96 DHODH (0.39) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL24788933 0.94 DHODH (0.42) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL24752731 0.94 DHODH (0.45) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL17853520 0.94 DHODH (0.46) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL19397371 0.94 DHODH (0.46) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL24788935 0.93 DHODH (0.37) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL26432023 0.92 KDM4E (0.43) DHODHKDM4EATML3MBTL1ALDH1A1
SCHEMBL24752498 0.92 KDM4E (0.43) DHODHKDM4EATML3MBTL1ALDH1A1
SCHEMBL26432145 0.91 DHODH (0.43) DHODHCYP19A1CYP11B1CYP17A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
EP-4101847-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed
EP-4101851-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, EPCAM, TMEM109 DHODH 3470/4885CYP19A1 395/4885CYP11B1 840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback